低分子肝素联合低分子右旋糖酐注射液预防人工全髋关节置换术后深静脉血栓临床效果和安(3)

来源:网络(WWW.NYLW.NET) 作者:李萌 刘长胜 发表于:2011-05-24 10:18  点击:
【关健词】  人工全髋关节置换;深静脉血栓;低分子肝素;低分子右旋糖酐
[5] 邱贵兴,杨庆铭,余楠生,等.低分子肝素预防髋、膝关节手术后下肢深静脉血栓形成的多中心研究.中华骨科杂志, 2006, 26(12):819-822. [6] 胥少汀.骨科手术并发症预防与处理.北京:人民军医出版社,2004:3-4.

  [5] 邱贵兴,杨庆铭,余楠生,等.低分子肝素预防髋、膝关节手术后下肢深静脉血栓形成的多中心研究.中华骨科杂志, 2006, 26(12):819-822.
  [6] 胥少汀.骨科手术并发症预防与处理.北京:人民军医出版社,2004:3-4.
  [7] 王强,盛伟斌,吴兵,等.低分子肝素预防老年髋关节周围骨折术.后下肢深静脉血栓的研究.现代中西医结合杂志,2009,18(20):2367-2369.
  [8] Zierler BK.Ultrasonography and diagnosis of venous thromboembo-lism.Circulation,2004,109(12 Suppl 1):19-14.
  [9] 邹华章,刘大柱,佟方明,等.老年髋关节置换术后下肢深静脉血栓的预防.中国骨与关节损伤杂志,2006,21(8): 916.
  [10] Clarke MT,Green JS,Harper WM,et al.Cement as risk factor fordeep-vein thrombosis.Comparison of cemented TKR,uncementedTKR and cemented THR.J Bone Joint Surg(Br),1998,80(4):611-613.
  [11] 张永顺,赵红梅,刘建青.联合低分子右旋糖酐和尿激酶抗血小板聚集的初步研究.中国现代药物应用,2010,4(15):15-16.
  [12] Blanchard J,Meuwly JY, Leyvraz PF, et al. Prevention of deep-veinthrombosis after total knee replacement. Randomised comparison betweena low-molecular-weight heparin (nadroparin) and mechanical prophylaxiswith a foot-pump system. J Bone Joint Surg Br,1999,81(4):654-659.
  [13] Hull R,Raskob G, Pineo G, et al. A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis againstdeep-vein thrombosis after hip or knee implantation. N Engl J Med, 1993, 329(19):1370-1376.
  [14] 王琦,张先龙,沈骏,等.“低风险”人群初次人工关节置换术后的深静脉血栓.中华骨科杂志,2007,27(2):106-109.
  [15] Hull RD,Pineo GF, Francis C, et al. Low-molecular-weight heparin pro-phylaxis using dalteparin in close proximity to surgery vs warfarin in hiparthroplasty patients: a double-blind, randomized comparison. ArchIntern Med,2000,160(14):2199-2207.
 

(责任编辑:南粤论文中心)转贴于南粤论文中心: http://www.nylw.net(南粤论文中心__代写代发论文_毕业论文带写_广州职称论文代发_广州论文网)
顶一下
(0)
0%
踩一下
(0)
0%


版权声明:因本文均来自于网络,如果有版权方面侵犯,请及时联系本站删除.